Regulator-mandated study finds no link between semaglutide use and pancreatic cancer

drug approval expired 100% Health

A regulator-mandated study using registry data from Denmark, Sweden, and Norway found no association between semaglutide use and pancreatic cancer. The findings were presented at the European Association for the Study of Diabetes annual meeting in Milan.

🇩🇰 Location: Milan — Sources: 7 — First seen: — Last seen:
semaglutide pancreatic cancer drug safety registry study Denmark

Linked Entities

University of Southern Denmark

organization involved

Anton Pottegård

person involved

Denmark

location involved 🇦🇺

Sweden

location involved 🇸🇪

Norway

location involved 🇳🇴

European Association for the Study of Diabetes

organization involved

AstraZeneca

organization involved

Summit Therapeutics

organization involved

Cancer Discovery

organization involved

Huntington's disease

organization involved

uniQure

organization involved

Mayo Clinic

organization involved

Jefferies

organization involved 🇫🇷

Syndax Pharmaceuticals

organization involved

Contributing Articles